glp-1 atlanta Weight Loss in GLP-1 Medications and Bloating: Why

High-Dose Semaglutide: STEP UP Trial Results The STEP UP trials, published in The Lancet Diabetes & Endocrinology, evaluated a 7.2 mg dose of semaglutide compared to the standard 2.4 mg dose

Increasing the dose of a GLP-1 can sometimes enhance weight loss or maintain consistent weight loss, explained Fatima Cody Stanford, MD, an obesity medicine scientist at Massachusetts General Hospital Digestive Healthcare Center in Boston

Using familiar clinical markers and intervening earlier is a much more modern, proactive model of care, she says

What Stays the Same in 2026 Weight loss exclusion continues on commercial and Medicare plans (unless BALANCE changes this) OSA coverage continues for Medicare members (AHI 15, BMI 27, no diabetes) Diagnosis code edits remain active claims still auto-reject for obesity codes For the latest Medicare policy details, see our Medicare coverage guide

Moreover, downregulation of GLP-1R level is also found in the glomerular endothelial cells of diabetic mice, which may be due to increased GLP-1R degradation resulted from diabetes-induced PKC2 activation 28

For instance, a provider might recommend remaining at 0.25 mg of semaglutide for eight weeks instead of four